OMTX 707
Alternative Names: OMTX-707Latest Information Update: 28 Oct 2024
At a glance
- Originator Oncomatryx
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer; Lung cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for research development in Breast-cancer in USA
- 28 Oct 2024 No recent reports of development identified for research development in Lung-cancer in USA
- 28 Oct 2024 No recent reports of development identified for research development in Ovarian-cancer in USA